StereotaxisSTXS +1.13%68 Buyback Yield % is -11.70 as of Jul. 03, 2026. GuruFocus rates STXS with a GF Score™ of 68/100 and a GF Value™ of $2.32 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 347 Medical Devices & Instruments companies, Stereotaxis ranks worse than 71.76% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Stereotaxis's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STXS vs PDEX, KRMD, EMBC: Buyback Yield % Comparison
For the Medical Instruments & Supplies subindustry, Stereotaxis's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Stereotaxis Buyback Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Stereotaxis's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Stereotaxis's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Stereotaxis (STXS) has a Buyback Yield % of -11.70 as of Jul. 03, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Stereotaxis and its competitors. According to the industry distribution chart, Stereotaxis ranks #249 out of 347 companies in the Medical Devices & Instruments industry, placing it in the top 71.8%.
Is Stereotaxis' Buyback Yield % too high?
Stereotaxis' current Buyback Yield % is -11.70. Based on the distribution chart, Stereotaxis ranks #249 out of 347 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Stereotaxis has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Stereotaxis' Buyback Yield % compare to PDEX and KRMD?
According to the Medical Devices & Instruments industry distribution chart, Stereotaxis ranks #249 out of 347 companies for Buyback Yield %. This places Stereotaxis in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Stereotaxis and its competitors. Stereotaxis's current Buyback Yield % is -11.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stereotaxis stock overvalued right now?
Based on GuruFocus' analysis, Stereotaxis (STXS) is currently considered Modestly Undervalued. The stock's GF Value™ is $2.32, compared to a current price of $1.79 — trading 22.8% below its estimated fair value. The current Buyback Yield % is -11.70. Stereotaxis' overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Stereotaxis (STXS), the current Buyback Yield % is -11.70 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Stereotaxis (STXS) Overvalued in 2026?
Based on GuruFocus' analysis, Stereotaxis stock appears to be undervalued.
The current stock price of $1.79 is trading 22.8% below its estimated GF Value™ of $2.32.
GuruFocus considers Stereotaxis to be Modestly Undervalued.
Key valuation signals for STXS:
Buyback Yield %: -11.70
GF Value™: $2.32 vs. price of $1.79 (22.8% below fair value)
No single metric tells the full story. See the STXS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.
68GF Score
Get the complete analysis for STXS
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STXS has been successfully added to your 
